Drug Data Import Component
Component that optimizes patient treatment transcription, saving time and reducing errors
Company profile
Company profile
Synapse Medicine is a healthcare technology company specializing in medication intelligence and clinical decision support systems. The company develops React Native components that seamlessly integrate into electronic health records (EHRs), e-prescribing software, and other clinical workflows to provide real-time medication guidance. Their platform aggregates official drug databases and employs artificial intelligence algorithms to deliver personalized clinical decision support, helping healthcare providers make safer and more efficient prescribing decisions. The company's flagship product, Synapse Prescribe, is ONC-certified and designed to reduce medication-related risks, prevent adverse drug reactions, and combat alert fatigue through intelligent, context-aware notifications. Synapse Medicine serves healthcare systems, telemedicine platforms, and software providers across multiple markets including the United States, France, and Japan. The company has established partnerships with major healthcare technology providers including CompuGroup Medical, Hellocare, and Lifen, and their technology is used by thousands of healthcare professionals daily. With a strong focus on research and development, Synapse Medicine continues to innovate in areas such as pharmacovigilance automation, herb-drug interaction databases, and precision medicine applications of AI.
Company description Synapse Medicine official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas deployment with recorded integration context.
Recorded integration context: Cerner, CompuGroup Medical, Epic, Hellocare, Lifen Platform, Surescripts.
Company milestones
Partnership with CompuGroup Medical announced May 2023. Gustave Roussy Institute integration February 2023. ONC certification achieved May 2025. COVID-19 platform helped 700,000+ people.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Component that optimizes patient treatment transcription, saving time and reducing errors
AI-powered pharmacovigilance technology for analyzing adverse drug reaction reports
Phytotherapy drug-interaction database for consistent herb-drug interaction risk assessment
Clinical decision support components for medication management integrated into EHRs and e-prescribing software
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Drug safety · May 1, 2026
Artificial intelligence in personalized prescription: A narrative review of promise, peril, and practicality.Therapie · Jan 1, 2026
A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness.Journal of clinical epidemiology · May 1, 2024
Will the future of pharmacovigilance be more automated?Expert opinion on drug safety · Jan 1, 2023
[Not Available].Therapie · Jan 1, 2023
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Therapie · Jan 1, 2023
Clinical validation
NCT05459155 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Reducing medication-related risks and adverse drug reactions
Context-aware, personalized clinical notifications
Streamlined prescription workflows and automated data transcription
COVID-19 platform usage
Partnership to revolutionize prescribing and clinical decision support for physicians
Brings users and patients innovation in clinical decision support, fits into roadmap for safer and more efficient healthcare system
Integration of Synapse Platform for clinical pharmacy and medication reconciliation at Europe's leading cancer center
Europe's leading cancer center and third-ranked globally chose Synapse Medicine for medication management
Clinical trial support for infectious disease research led by Professor Denis Malvy
Supported clinical trial promoted by Bordeaux University Hospitals for infectious disease research
Telemedicine platform using Synapse Medicine to ensure prescription safety during telehealth consultations
Simplified and smoothed healthcare pathways through secure telemedicine prescribing
Built COVID-19 platform in 72 hours to help healthcare professionals and general public during pandemic
Helped 700,000+ people with COVID-19 medication guidance and information
Integration of Synapse Medicine's API and components into Hellocare platform for safer prescribing in telehealth consultations
Makes it easier to prescribe safely, ensures safety of telehealth consultations while facilitating real-time decision-making
Partnership to extend interoperability to medication reconciliation and medication management of patients
Continues desire to improve patient care through enhanced medication management capabilities
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dr. Clément Goehrs
Co-Founder & CEO
Franck Frayer
SVP Europe
Morgan Angelini
CTO
Franck le Ouay
CEO
Marie-Laure Saillard
CEO
06 · Company updates
Recent articles published on Synapse Medicine's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.